visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Novavax

    Get Full Access

    Description

    • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. In addition, the company develops vaccine candidates for the protection against middle east respiratory syndrome, as well as that is in preclinical work associated with severe acute respiratory syndrome; and ebola virus glycoprotein vaccine candidate, as well as COVID-19 vaccine for variant strain. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
    • location

      Headquarters:21 Firstfield Road , Gaithersburg, Maryland, United States

      More
    • Novavax phone

      Phone Number: +1 240-268-2000

    • Novavax website

      Website: https://www.novavax.com

    • Novavax employees

      Employees:385

    • Novavax revenue

      Revenue:$250 - 500M

    • Novavax legal name

      Legal Name:Novavax

    • Novavax's Social Media

      Novavax linkedin Novavax twitter
    • done Is this data correct?

    • |  NAICS Code: 446110  |

        NYSE: NVAX

      Show More
    Person level website identification

    CEO for Novavax

    Rahul Singhvi

    President And Chief Executive Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Jim Kelly

    Executive Vice President And Chief Financial Officer

    Rick Crowley

    Chief Operations Officer

    John Herrmann

    Executive Vice President, Chief Legal Officer

    Filip Dubovsky

    Chief Medical Officer

    Greg Glenn

    President, Research And Development, Novavax

    Frequently Asked Questions regarding Novavax

    • Where are Novavax's Headquarters?

      Novavax's Headquarters are in 21 Firstfield Road ,Gaithersburg,Maryland,United States

    • What is Novavax's phone number?

      Novavax's phone number is +1 240-268-2000

    • What is Novavax's stock symbol?

      Novavax's stock symbol is NVAX

    • What is Novavax's official website?

      Novavax's official website is https://www.novavax.com

    • What is Novavax's Revenue?

      Novavax's revenue is $250 - 500M

    • What is Novavax's NAICS code?

      Novavax's NAICS code is 446110

    • How many employees are working in Novavax

      Novavax has 385 employees

    • What is Novavax's Industry?

      Novavax is in the industry of Pharmaceuticals

    Company Directory